Drug development and registration: Challenges and opportunities in ovarian cancer
- PMID: 28499074
- DOI: 10.1002/cncr.30645
Drug development and registration: Challenges and opportunities in ovarian cancer
Comment on
-
Regulatory considerations on endpoints in ovarian cancer drug development.Cancer. 2017 Jul 15;123(14):2604-2608. doi: 10.1002/cncr.30652. Epub 2017 May 12. Cancer. 2017. PMID: 28499075 Review.